Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Aldeyra Seeks FDA Division Transfer for ADX-2191 in PVRL

Aldeyra Therapeutics, Inc. filed a Form 8-K on November 9, 2026, disclosing that it has formally requested a review jurisdiction transfer for its ADX-2191 Investigational New Drug application and has withdrawn the previously agreed Special Protocol Assessment protocol for the treatment of primary vitreoretinal …

Shwetambri Chauhan | 09 November 2026

Lantronix Q1 Fiscal 2027 Results Announced Nov. 9

Lantronix, Inc. filed a current report on November 9, 2026, disclosing its financial results for the first fiscal quarter ended September 30, 2026, alongside a transcript of management's prepared remarks for the accompanying investor conference call.

Vinay Lochav | 09 November 2026

James River Group Declares $0.01 Dividend, Reports Q3 2026 Results

James River Group Holdings, Inc. filed a Form 8-K on November 9, 2026, announcing its financial results for the quarter ended September 30, 2026, and disclosing a cash dividend declaration by its Board of Directors.

Manish Choudhary | 09 November 2026

Paysign Q3 2026 Revenue Hits $30.8M, Up 43%

Paysign, Inc. filed a current report on Form 8-K on November 9, 2026, disclosing third-quarter 2026 financial results through a press release furnished as Exhibit 99.1.

Aakashdeep | 09 November 2026

Thryv Holdings Reports Nine-Month Earnings on November 9, 2026

Thryv Holdings, Inc. filed a current report on November 9, 2026, disclosing its earnings results for the nine months ended September 30, 2026, alongside an investor presentation furnished under Regulation FD.

Aditi Sarkar | 09 November 2026

Digital Turbine Files Q3 FY2026 Earnings 8-K

Digital Turbine, Inc. filed a Form 8-K with the SEC on November 9, 2026, disclosing that it issued a press release announcing financial results for the quarter ended September 30, 2026.

Anjali Anand | 09 November 2026

Kustom Entertainment Extends TFL Deal Deadline to Dec 18

Kustom Entertainment, Inc. filed a Form 8-K on November 9, 2026, disclosing that it entered into an amendment to its Unit Purchase Agreement with TFL, LLC on November 6, 2026, extending the outside termination date for the proposed transaction to December 18, 2026.

Nitish Kishor | 09 November 2026

ArriVent R&D Head Lutzker to Retire; Patel Takes Over Dec. 1

ArriVent BioPharma, Inc. filed a Form 8-K on November 9, 2026, disclosing the planned retirement of President of Research and Development Stuart Lutzker, M.D., Ph.D., effective December 1, 2026, along with the appointment of Chief Medical Officer Priti Patel, M.D., to lead the company's …

Aditi Sarkar | 09 November 2026

Park Dental Closes Village Family Dental Acquisition Nov. 6

Park Dental Partners, Inc. filed an 8-K on November 9, 2026, reporting the November 6, 2026 completion of its acquisition of the dental services organization supporting Village Family Dental and the related amendment to its credit facility.

Shwetambri Chauhan | 09 November 2026

Sanmina Adds $70M Term Loans, Extends Credit to 2031

Sanmina Corporation filed a Form 8-K on November 9, 2026, disclosing Amendment No. 5 to its senior secured credit agreement, which added $70 million in incremental term loans and extended the maturity of key credit facilities to October 28, 2031, while also announcing unaudited …

Nitish Kishor | 09 November 2026
Support

Hi! How can we help you today?

Loading…